Cito Putra Utama

What Cito Putra Utama does

PT Cito Putra Utama (CITO) is an Indonesian private healthcare services company founded in 1967 by Bp. Achmad Djoeahir and headquartered in Semarang, operating 251–500 employees across 9+ branches in Java and Kalimantan. The business is structured as three integrated units: Laboratorium Medis (medical laboratory with 300+ tests spanning hematology, clinical chemistry, immunology, microbiology, genetics, and anatomical pathology), Klinik Utama (primary and secondary healthcare clinic), and Riset Medis (medical research), anchored by the Beranda CITO mobile application that provides online lab results, appointment booking, home service sampling, and the Ready Dokter telemedicine feature.

CITO generates revenue predominantly through unit-priced laboratory examinations and Medical Check-Up (MCU) packages priced between Rp 350,000 and Rp 2,800,000, with specialty verticals in OGUK/OEUK certification for offshore oil and gas workers, genetic testing under the CitoGen brand (BRCA, cancer risk, HPV, pharmacogenomics, nutrigenomics), clinic consultations, and digital health services including the Ready Dokter telemedicine tier. Distribution combines a physical branch network, a mobile/home sample-collection service, a web storefront for MCU vouchers, and a corporate sales motion for enterprise MCU and occupational health programs. Promotional levers include a recurring 20% Customer Day discount on the 9th–10th of each month and Health Harmony package campaigns.

The company's go-to-market spans individual consumers (primary), corporate enterprise MCU clients, offshore oil and gas workers requiring OGUK/OEUK certification, and Hajj pilgrims needing pre-departure health clearance. Digital initiatives under the 2026 'Transformation Towards Excellent Performance' Resolution incorporate AI-powered health-risk mapping, predictive result recommendations, process automation across registration and lab reporting, and an AI chatbot (Alana Virtual) — features that have been externally recognized through a Harvard Medical School capstone Distinction and multiple 2025–2026 Indonesian brand and customer-service awards (Satria Brand, SWA, MarkPlus WOW Brand).

Name

Cito Putra Utama

Legal name

PT CITO PUTRA UTAMA

Website

https://labcito.co.id

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

251–500 employees

Short description

PT Cito Putra Utama is an Indonesian private medical laboratory, clinic, and medical research operator founded in 1967, serving individual consumers, corporate clients, offshore oil and gas workers, and Hajj pilgrims through 9+ branches and the Beranda CITO digital platform.

Ownership category

akta.pro rank

Headquarters

HQ city

Semarang

HQ country

Indonesia

HQ region

Asia

Offices9 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Laboratory Testing Services: Core revenue stream from comprehensive medical laboratory examinations including hematology, clinical chemistry, immunology, genetics, microbiology, and pathology. Services provided at branch locations and via home service sampling.
2. Medical Check-Up (MCU) Packages: Comprehensive health examination packages for individuals and corporate clients, including specialized packages for heart, cancer screening, liver, kidney, lung, and metabolic health. Also includes occupational health MCU for Hajj pilgrims and OGUK certification for oil & gas workers.
3. Clinic Services: Primary and secondary healthcare services through Klinik Utama with experienced doctors, providing consultation and treatment services.
4. Digital Health Services: Telemedicine consultations via Ready Dokter feature, online result access, and appointment booking through Beranda CITO application.
5. Medical Check-Up Voucher Sales: Retail sale of MCU vouchers for examinations conducted at CITO laboratory branches, processed through web shopping platform.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Core offering

PT Cito Putra Utama (CITO) operates an integrated private healthcare business in Indonesia spanning clinical laboratory diagnostics, primary and secondary clinic services, and medical research. Its core revenue-generating offering is comprehensive medical laboratory testing supported by the Beranda CITO mobile application for digital result access, home sample collection, and AI-driven health recommendations, alongside occupational health certifications (OEUK/OGUK) for offshore workers, genetic testing (CitoGen), and tiered medical check-up (MCU) packages.

Product overview

CITO (PT Cito Putra Utama) is a healthcare company established in 1967 offering three integrated business units: Laboratorium Medis (Medical Laboratory), Klinik Utama (Primary/Secondary Healthcare Clinic), and Riset Medis (Medical Research). The company provides a comprehensive portfolio of health services centered around its digital platform, Beranda CITO mobile application, which integrates online laboratory results, telemedicine consultations via Ready Dokter, home service sampling, and health promotions. Core diagnostic services include medical laboratory examinations (hematology, clinical chemistry, immunology, microbiology, genetics, anatomical pathology), genetic testing under CitoGen brand (BRCA, cancer risk, HPV, pharmacogenomics, nutrigenomics, STI panels), and specialized health screening packages (Heart Harmony, Lung Care, Digestive, Cancer Care, MCU packages). Occupational health services include OEUK/OGUK medical examinations for offshore workers. AI-powered services include Alana Virtual chatbot for customer inquiries and AI-powered health risk recommendations. The company operates multiple branch locations across Indonesia including Semarang, Surabaya, Balikpapan, Bogor, and others, with digital services accessible nationwide.

Differentiator

Problem solved

Functional benefit

Brands

• Beranda CITO: Mobile health application for accessing laboratory results, booking services, health history tracking, and health information.
• CitoGen
• Ready Dokter
• Alana Virtual
• Cito Virtual Consultation (CVC)
• Cito Mobile Service (CMS) / Home Service

Products and services

• Laboratorium Medis CITO (Medical Laboratory Services) Comprehensive clinical laboratory testing covering hematology, clinical chemistry, immunology, microbiology, genetics, and anatomical pathology with online result access via the Beranda CITO platform. Serves individual patients, corporate clients, and occupational health programs across 9+ Indonesian branches.
• Klinik Utama CITO (Primary and Secondary Healthcare Clinic) Primary and secondary outpatient healthcare services staffed by experienced doctors at CITO branch locations across Indonesia, providing consultation, treatment, and integrated referral to CITO laboratory and research services.
• Riset Medis CITO (Medical Research Division) Medical research division developing innovative health solutions for societal benefit and supporting evidence-based laboratory and clinical services across CITO's operations.
• Beranda CITO Mobile Application Digital health application available on Google Play and Apple App Store providing online laboratory result access, appointment scheduling, home service booking, health history tracking, health education content, and integrated Ready Dokter telemedicine consultations for individual consumers across CITO's service area.
• Home Service (Cito Mobile Service / CMS)

Quantifiable outcome

• Online results access eliminates physical document retrieval and queuing
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core and supporting.

• ALSTE Indonesia (Ikatan Alumni SMA Negeri 3 Semarang)coreStrategic or Co-development Partner · 22 June 2026Memorandum of Understanding signed on June 22, 2026 at CITO Jalan Indraprasta, Semarang. Strategic collaboration focused on health initiatives and community engagement with alumni association.
• Jobstreet by SEEK and Markplus InstitutesupportingStrategic or Co-development Partner · 20 January 2026Co-presentation at Next Gen Founder 2026 event focused on business sustainability and intergenerational succession, with dr. Shabrina Mayangsari as speaker.
• JNE ExpresssupportingChannel Partner/ Reseller/ Distributor · 5 December 2025Logistics partnership for disaster relief distribution, enabling structured and timely aid delivery to flood-affected communities in Sumatra.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Parahita Diagnostik: Parahita Diagnostik is an Indonesian diagnostic laboratory network offering clinical chemistry, immunology, microbiology, and MCU packages. It directly competes with CITO in the Central and East Java markets with comparable service portfolios and consumer-facing positioning.
• Biotest Indonesia: Biotest Indonesia is an Indonesian clinical laboratory offering diagnostic testing and health screening services with branch locations across major cities. It is a direct competitor to CITO in the same clinical laboratory category serving consumers and corporate MCU clients.
• Bio Medika: Bio Medika is an Indonesian clinical laboratory chain providing routine and specialized diagnostic testing with multi-city branches. It overlaps with CITO's clinical laboratory, MCU package, and home service offerings for individual and corporate customers.
• Prodia: Prodia is the largest clinical laboratory chain in Indonesia, operating 150+ branches nationwide with comprehensive hematology, chemistry, immunology, and genetic testing services. It is the most direct competitor to CITO, serving the same individual consumers, corporate MCU clients, and clinician referral base with a similar test menu and home service model.
• Pramita: Pramita is a long-established Indonesian clinical laboratory chain offering diagnostic testing, MCU packages, and home service sampling comparable to CITO's core offerings. It serves both consumers and corporate clients across multiple Indonesian cities, making it a direct regional peer in the same service category.

Emerging players

• Bumame Farmasi: Bumame is an Indonesian health tech startup combining pharmacies, clinical laboratory services, and at-home sample collection via a digital-first platform. While younger and more venture-backed, it directly competes with CITO's home service model and Beranda CITO app, particularly in digital-savvy urban markets.

Broad incumbents

• Kimia Farma Diagnostika: Kimia Farma Diagnostika is the diagnostic arm of state-owned PT Kimia Farma, leveraging a nationwide pharmacy network plus dedicated laboratory outlets. Comparable to CITO in clinical lab services and MCU packages, with added distribution advantage from parent company's retail footprint and broader health ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/labcito
• Instagraminstagram.com/labcito
• Xx.com/labcito
• LinkedInlinkedin.com/company/pt-cito-putra-utama

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cito Putra Utama